-+ 0.00%
-+ 0.00%
-+ 0.00%

CULLINAN THERAPEUTICS, - TAIHO ONCOLOGY, TAIHO PHARMACEUTICAL, CULLINAN THERAPEUTICS TO PURSUE U.S. REGULATORY APPROVAL FOR ZIPALERTINIB COMBINATION

Reuters·08/13/2026 10:04:18

Please log in to view news